Who has invested in MeiraGTx?

Sanofi, Oberland Capital are named among the investors backing MeiraGTx.

MeiraGTx Funding: $585M Raised, IPO (2026)

MeiraGTx funding overview

MeiraGTx is based in New York, NY. MeiraGTx has raised $585M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in July 2026. The round record for MeiraGTx runs through 2026; nothing later has been disclosed. Investors on record include Sanofi, Oberland Capital. 2 distinct backers are named across the disclosed rounds.

MeiraGTx at a glance

Total raised: $585M
Latest round: IPO
Latest round date: July 2026
Headquarters: New York, NY
Notable investors: Sanofi, Oberland Capital

Frequently asked about MeiraGTx funding

How much has MeiraGTx raised?: MeiraGTx has raised $585M in total disclosed funding across the rounds on record.
Who has invested in MeiraGTx?: Sanofi, Oberland Capital are named among the investors backing MeiraGTx.
What was the latest MeiraGTx funding round?: The most recent disclosed round is an IPO, announced in July 2026.
Where is MeiraGTx based?: MeiraGTx is based in New York, NY.
When did MeiraGTx last raise?: The last disclosed MeiraGTx round closed in July 2026 at IPO.

Round data for MeiraGTx is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York and backer lists below.

MeiraGTx Funding: $585M Raised, IPO (2026)

MeiraGTx funding overview

MeiraGTx at a glance

Frequently asked about MeiraGTx funding

Companies related to MeiraGTx (36)

Browse related funding lists (6)